Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response
- 27 October 2010
- Vol. 29 (1) , 17-25
- https://doi.org/10.1016/j.vaccine.2010.10.024
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1Vaccine, 2010
- Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenicVirology, 2010
- Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humansVaccine, 2009
- Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challengeVirology, 2008
- A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animalsVirology, 2008
- Pathogen evolution and disease emergence in carnivoresProceedings Of The Royal Society B-Biological Sciences, 2007
- Isolates of Zaire ebolavirus from wild apes reveal genetic lineage and recombinantsProceedings of the National Academy of Sciences, 2007
- Successful Topical Respiratory Tract Immunization of Primates against Ebola VirusJournal of Virology, 2007
- Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogensProceedings of the National Academy of Sciences, 2007
- Nonsegmented Negative-Strand Viruses as Vaccine VectorsJournal of Virology, 2006